RayzeBio’s Post

Be sure to sign up on the below link for some lively discussion and interesting insights for tomorrow's webinar on Life Science virtual start-ups!

As we enter 2024, FSPs have re-emerged as one of the most efficient resourcing models as the biopharma industry tries to rebound from a turbulent 2023. In our new FSP case study, we share how we helped an oncology biopharmaceutical company implement an FSP model to enhance their clinical development strategy and support operational teams. Read more here: https://hubs.la/Q02hJkqQ0 #fsp #functionalserviceprovider #clinicaldevelopment #clinicalresearch

In 2023 we saw 55 ADCs enter the clinic for the first time bringing the number up to 331 assets that have entered the clinic! Some notable advancements: 🌏 Pfizer & Pyxis Oncology: PYX-201 🌏 Abmart & Multitude Therapeutics: AMT-116 🌏 Daiichi Sankyo, Inc. & Glycotope GmbH: DS-3939 🌏 Antengene: ATG-022 🌏 Bio-Thera Solutions: BAT8007 🌏 Sino Biopharmaceutical Limited: TQB2103 📈 The accompanying graph illustrates the dynamic progression of ADC assets in 2023, showcasing 12 ADCs advancing from phase 1/1-2 to phase 2. Additionally, 9 ADCs initiated phase 3 trials, marking significant progress from earlier-stage trials. #adc #adcs #antibodydrugconjugates #antibodydiscovery #trials #pharmaceutical #clinicalresearch #antibodies

Great webinar about the "cancer drug discovery" This event was meticulously organized by the society of pharmaceutical sciences and research (SPSR) #pharmacy #knowledge #pharmaceuticalscience

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/gGF6T2my #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/gF9xm9AW #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/ghz9adkf #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/g483k2Xi #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/gX3CkWZy #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth

Learn how Calyx #MedicalImaging delivered critical imaging data in advance of deadlines on an expedited timeline to help a leading pharmaceutical company receive #Accelerated FDA approval for a #MultipleMyeloma treatment. https://lnkd.in/d5kgG7kB #ChooseCalyx #ClinicalTrials #Oncology Jason Xu #MyelomaActionMonth